News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
Biotech/Pharma - Mergers and Acquisitions
Roche (RHHBY) To Pay Up To $489 Million For Next-Gen Antibody Firm Dutalys 12/19/2014
Hedge Fun Takes Stake In Salix Pharmaceuticals, Ltd. (SLXP); Other Top Investors Push For Sale Of Company 12/19/2014
RedHill Biopharma Ltd. (RDHL) Acquires Technology From University of Minnesota As Part Of Ongoing RHB-104 Phase 3 Crohn's Program 12/18/2014
Merck & Co. (MRK) Snaps Up Swiss Biotech In $375 Buyout Deal 12/18/2014
Shire (SHPGY) May Spend AbbVie (ABBV) Breakup Fee On NPS Pharmaceuticals, Inc. (NPSP); NPS Surges On Rumor 12/18/2014
KCR Acquires Project Portfolio From Ukrainian CRO AXIS 12/18/2014
FUJIFILM Completes Acquisition Of Kalon Biotherapeutics 12/18/2014
Prima Biomed (PRR.AX) Completes Immutep S.A. Acquisition 12/18/2014
UCB SA Terminates $1.53 Billion Sale Of Generic Drug Unit To Buyout Firms 12/17/2014
Evolva A/S Unloads EV-035 Series To Emergent BioSolutions (EBS) For $70.5 Million Plus 12/17/2014
Emergent BioSolutions (EBS) Expands Biodefense Franchise; Acquires Portfolio Of Broad Spectrum Antibiotics 12/17/2014
Novartis AG (NVS) Takes Stake In Israeli Biopharma BioLine; Makes $10 Million Investment 12/16/2014
Renmatix Acquires Sweden-Based REAC Fuel's Intellectual Property 12/16/2014
Geron Corporation (GERN) Announces Early HSR Clearance For Global Strategic Collaboration With Janssen Biotech Inc. (JNJ) 12/16/2014
PerkinElmer, Inc. (PKI) Completes Acquisition Of Perten Instruments 12/16/2014
Baxter International, Inc. (BAX) To Divest Vero Cell Vaccines Platform To Nanotherapeutics 12/15/2014
Endo International (ENDP) Registration Statement Relating To Pending Auxilium Pharmaceuticals (AUXL) Acquisition Declared Effective By The SEC 12/12/2014
Abbott Laboratories (ABT) Completes Acquisition Of Veropharm 12/12/2014
Sosei Group Corporation Acquires Jitsubo, A Leading Japanese Peptide Technology Company 12/12/2014
Cipla Ltd. Sells Stake In Jiangsu Cdymax Pharma For $18.5 Million 12/12/2014
Danaher (DHR) Completes Acquisition Of Nobel Biocare (NOBN.VX) 12/11/2014
Migranade, Inc. Initiates Negotiations To Acquire The Exclusive World-Wide Rights To Manufacture And Market Itonis, Inc.'s EMESYL Nausea Relief 12/11/2014
Drug Giant Merck & Co. (MRK) Buys Cubist Pharmaceuticals, Inc. (CBST) For $9.5 Billion 12/11/2014
Interim CEO Says Sanofi (SAN.PA) Continuing Diversification, Eyeing Acquisitions 12/10/2014
Valeant (VRX) To Drop Deal-Making To Cut Debt, Boost Stock 12/10/2014
Endo Pharmaceuticals (ENDP) Completes Acquisition Of Rights To Natesto Testosterone Nasal Gel 12/9/2014
Natrol, Inc. Completes Sale To Aurobindo Pharma USA Inc. 12/9/2014
Sigma-Aldrich Corporation (SIAL) Stockholders Approve Acquisition By Merck KGaA (MKGAF.PK) 12/8/2014
Neogen Corporation (NEOG) Acquires Assets Of Its Chinese Distributor 12/8/2014
KKR Takes Undisclosed Stake In Arbor Pharmaceuticals As Specialty Funding Heats Up 12/5/2014
Helix Biopharma (TSX:HBP) Says It Plans To Go Shopping Soon 12/5/2014
Speculation Mounts That Pfizer (PFE) Will Up Bid For AstraZeneca PLC (AZN) As Cooling Off Period Ends 12/5/2014
China, South Korea OK GlaxoSmithKline (GSK)'s $43B Covidien (COV) Buy 12/5/2014
Genetics Policy Institute (GPI) Release: Two Leading Stem Cell and Regenerative Medicine Advocacy Groups Announce Merger Plan 12/4/2014
Ally Pharma US Executes Merger 12/4/2014
Forbion Announces Sale Of Portfolio Company PneumRx Inc. To BTG plc (BTG.L) For Up To EUR 385M (USD 475M) 12/4/2014
Roche (RHHBY) Acquires Ariosa Diagnostics, Inc. And Enters The Non-Invasive Prenatal Test (NIPT) And Cell-Free DNA Testing Services Markets 12/3/2014
Noble Life Sciences Inc. Acquires Spring Valley Laboratories, Inc. 12/3/2014
Alizé Acquires Exclusive Worldwide Rights On A New Peptide To Tackle Bone Diseases 12/3/2014
Shanghai Fosun Buys 65% Stake In Suzhou Erye Pharma 12/3/2014
Otsuka Pharmaceutical Co., Ltd. Buys AVANIR Pharmaceuticals (AVNR) For $3.5 Billion 12/2/2014
Pfizer (PFE) Completes Acquisition Of Baxter International, Inc. (BAX)’s Marketed Vaccines 12/2/2014
Pfizer (PFE) Announces Completion Of Merger With Wyeth 12/2/2014
Contera Pharma Announces Acquisition By Korean Bukwang Pharmaceutical 12/1/2014
Imaflex Acquires Controlled-Release Agricultural Mulch Film Assets From Bayer AG (BAYZF) 12/1/2014
European Commission (EC) Regulators Mull Novartis AG (NVS), GlaxoSmithKline (GSK) Deals As January Deadline Looms 12/1/2014
Cocrystal Pharma And RFS Pharma LLC Merge To Create Advanced Antiviral Development Organization 11/26/2014
Regen BioPharma Acquires University of Toronto Cancer Stem Cell Intellectual Property 11/25/2014
BioMarin Pharmaceutical Inc. (BMRN) Acquires ProSensa Holding N.V. (RNA) For Up To $840M; Gaining Experimental Drisapersen 11/24/2014
EXCLUSIVE: Ackman Says “Biggest Mistake” In Allergan (AGN) Bid Was Tender Offer 11/21/2014
AbbVie (ABBV) Acquires Manufacturing Facility In Singapore; Further Expands Capabilities In Asia 11/21/2014
The Rohatyn Group Completes Sale of 36.6% Huvepharma Stake To Advance Properties 11/20/2014
Knight Therapeutics Sells Priority Review Voucher To Gilead Sciences, Inc. (GILD) For US$125 Million Cash 11/20/2014
Apellis Pharmaceuticals To Acquire Potentia Pharmaceuticals, Inc. 11/20/2014
Migranade, Inc., The Maker Of MIGRANADE Migraine Relief, Acquires Oasis Health Care Products, Inc. 11/19/2014
Endo Pharmaceuticals (ENDP) Announces Early Termination Of HSR Act Waiting Period In Connection With Its Proposed Acquisition Of Auxilium Pharmaceuticals (AUXL) 11/19/2014
Ricerca Biosciences, LLC Release: Acquired By Growth-Oriented Equity Investment Group 11/18/2014
Actavis (ACT) Agrees To Buy Allergan (AGN) For $66 Billion 11/18/2014
Valeant (VRX) Buys Nicox In $20 Million Deal 11/17/2014
Actavis (ACT) To Acquire Allergan Inc. (AGN) To Create Top 10 Global Growth Pharmaceutical Company With $23 Billion In Revenue 11/17/2014
Zoetis (ZTS) To Purchase Assets Of Abbott Animal Health 11/17/2014
PE Firm To Bid For GlaxoSmithKline (GSK)'s $3 Billion Mature Drugs Portfolio 11/14/2014
Deal-Hungry Pfizer (PFE) Unlikely To Make Fresh Bid For AstraZeneca PLC (AZN) 11/14/2014
Actavis (ACT) In Talks To Buy Allergan Inc. (AGN) For Over $60 Billion 11/14/2014
Recipharm AB Bags Lusomedicamenta For $140 Million 11/14/2014
Jubilant Life Sciences (JOL) Seeks To Complete Buyout Of U.S.-Based Cadista For Up To $33.2 Million 11/14/2014
AMAG Pharmaceuticals, Inc. (AMAG) Completes Acquisition Of Lumara Health's Maternal Health Business 11/13/2014
Nuvo Research Inc. (NRI.TO) Reacquires Pennsaid® 2% Rights To South America, Central America, South Africa And Israel 11/13/2014
Zoetis (ZTS) May Be Valeant (VRX)'s Plan B 11/13/2014
Sanofi (SAN.PA) Unloads Large Office In India 11/13/2014
Ackman Takes $2 Billion Stake In Zoetis (ZTS) 11/12/2014
Thailand-Based SCG Acquires Stake In Liechtenstein-Based Research Company Lysando AG 11/12/2014
AstraZeneca PLC (AZN) Is Building Value Without Pfizer (PFE): CEO 11/11/2014
Johnson & Johnson (JNJ) Announces Completion Of Alios BioPharma Acquisition 11/10/2014
Johnson & Johnson (JNJ) Chief Eyes Acquisitions In China 11/10/2014
UCB Group (UCBJF.PK) Divests U.S. Generics Unit For $1.53 Billion 11/7/2014
PDL BioPharma, Inc. (PDLI) Pays $65.6 Million For Portion Of University of Michigan's Royalty Interest In Genzyme Corporation (GENZ) Drug 11/7/2014
VWR, Inc. Acquires Integra Companies, Inc. And STI Components, Inc. 11/7/2014
Perrigo Company (PRGO) Snatches Up Omega Pharma NV (0OMEP.BR) For $4.5 Billion 11/6/2014
Aegerion Pharmaceuticals, Inc. (AEGR) Pays $325 Million Upfront For AstraZeneca PLC (AZN)'s Myalept™ 11/6/2014
Laboratory Corporation of America Holdings (LabCorp) (LH) Snatches Up Covance Inc. (CVD) For $6.1 Billion 11/6/2014
Eurofins Acquires SF Analytical Labs Increasing Midwest Footprint 11/6/2014
ERT Announces Acquisition Of eClinical Insights 11/6/2014
GVK BIO Signs Definitive Agreement To Acquire Vanta Bioscience 11/6/2014
Instem Release: Leading Chinese Research Institute Purchases Provantis Preclinical Software Solution For Shanghai Headquarters 11/6/2014
Allergan Inc. (AGN) Confirms Second Suitor Wants To Buy It, Is It Actavis (ACT)? 11/5/2014
AstraZeneca PLC (AZN) Builds Cancer Immunotherapy Capabilities With $150 Million Definiens AG Buy 11/4/2014
Sigma-Aldrich Corporation (SIAL) Completes Acquisition Of Cell Marque 11/4/2014
Univar Expands in Brazil Market With Acquisition Of D'Altomare Quimica Ltda. 11/4/2014
Taiyo Pacific Partners Becomes Major Shareholder In Peptidream With Stake Over 5% 11/4/2014
NEMUS Completes Reverse Merger With Load Guard Logistics, Inc. 11/4/2014
Cantel Medical (CMN) Acquires International Medical Service S.r.l. 11/4/2014
AbbVie (ABBV) Not Looking For Massive Deals After Abandoning Shire 11/3/2014
AbbVie (ABBV)'s Strong Results Lessen Need For Big Deal 11/3/2014
Mesa Labs (MLAB) Acquires Its UK And Irish Republic Distributor Of Biological Indicators 11/3/2014
Actavis (ACT) And Durata Therapeutics, Inc.  (DRTX) Receive U.S. FTC Clearance For Actavis' Proposed Acquisition Of Durata 11/3/2014
AVANIR Pharmaceuticals (AVNR) Gives Suitors Two Big Reasons To Bid 10/31/2014
Deal-Starved Perrigo Company (PRGO) In Exclusive Talks To Buy $5 Billion+ Omega Pharma NV (0OMEP.BR) 10/31/2014
Paratek Pharmaceuticals, Inc. Completes Merger With Transcept Pharmaceuticals, Inc. (TSPT) 10/31/2014
Sterigenics International, Inc. Continues Growth With Acquisition Of Leading Italian Sterilization Firm 10/31/2014
Abbott Laboratories (ABT) Pays $250 Million For Menlo Park Startup Topera 10/30/2014
Bayer AG (BAYZF) Hunts For More Deals After Bulking Up Consumer Care 10/30/2014
PerkinElmer, Inc. (PKI) Acquires Ceiba Solutions, Inc. 10/30/2014
PDI, Inc. (PDII) Confirms Receipt Of Unsolicited Acquisition Proposal From Digirad Corporation (DRAD) 10/30/2014
Valeant (VRX): We Will Bump Allergan Inc. (AGN) Offer To $200 A Share 10/28/2014
Novartis AG (NVS) Sells Flu Vaccine Business For $275 Million To CSL Limited (CMXHF.PK) 10/28/2014
Luye Pharma Pays $390 Million For Remaining 42% Of Beijing Jialin Pharma 10/28/2014
Zogenix, Inc. (ZGNX) Snags U.K.-Based Brabant Pharma In $35 Million Cash-Stock Deal 10/27/2014
Pfizer (PFE)'s $11 Billion Buyback Dims Prospects Of AstraZeneca PLC (AZN) Bid 10/27/2014
MPI Research Acquires Jasper Clinical Research & Development 10/27/2014
Institutional Investor Lincoln Park Capital Increases Ownership In Anavex Life Sciences Corp. (AVXL.OB), Pays Over 25% Premium To Market 10/27/2014
Allergan Inc. (AGN) Comments On Valeant (VRX) Letter 10/27/2014
CTI BioPharma Grabs Exclusive Worldwide Rights To Tosedostat 10/27/2014
New Actavis (ACT) CEO Has $70 Billion In Deals To Choose From 10/24/2014
Private Equity Eyes $13 Billion Bayer AG (BAYZF)'s Plastics Business 10/24/2014
Acorda Therapeutics (ACOR) Completes Acquisition Of Civitas Therapeutics 10/23/2014
Mylan Inc. (MYL), Abbott Laboratories (ABT) Tweak $5 Billion Tax Inversion Deal 10/23/2014
Actavis (ACT) Pays $40 Million Upfront; Snags Option To Buy Rhythm Health 10/22/2014
Ferring Pharmaceuticals To Acquire Marketing Rights For DDAVP® (desmopressin) Product Portfolio From Sanofi (SAN.PA) 10/22/2014
BioNano Genomics's Irys System Adopted By Leading Genomics Centers For Comprehensive Detection Of Human Genome Structural Variation 10/22/2014
Actavis (ACT) Will Compete With Sanofi (SAN.PA) For $5.1 Billion Omega Pharma NV (0OMEP.BR) Deal 10/21/2014
Lupin Ltd. (LUPN.BO) Scouts For Acquisitions In U.S. 10/21/2014
Valeant (VRX) Hints At Higher Bid For Allergan Inc. (AGN) 10/21/2014
Shire Goes Shopping After AbbVie (ABBV) Deal Falls Through 10/21/2014
Nanion Release: Prestigious Academic Facility At Northwestern University Acquires The SyncroPatch 384/768PE 10/21/2014
AbbVie (ABBV) Officially Abandons Shire 10/21/2014
Medican Enterprises Signs Binding Letter Of Intent To Acquire Indoor Growing And Hydroponic Equipment Manufacturer Future Harvest Development 10/21/2014
Therapix Signs Non-Binding Agreement to Acquire Dekel Pharmaceuticals Ltd. 10/21/2014
Fresenius AG, Buyout Groups Eye Danone Medical Nutrition Unit 10/20/2014
BioProcess Technology Consultants, Inc. Acquires CTD Quality Consulting, Launches New advanceONE™ Division 10/20/2014
AbbVie (ABBV) Board Officially Abandons $55 Billion Shire Merger 10/17/2014
Horizon Biopharm Pays $45 Million Cash For U.S. Rights To PENNSAID® 2% 10/17/2014
DiaGenic ASA: Completed Acquisition Of NEL Hydrogen – Company Name And Ticker To Be Changed 10/17/2014
Virax To Acquire Deep AKT Inhibitor Portfolio Already In Phase 1b/2 Breast & Phase 1b Ovarian Cancer Trials 10/17/2014
Lawyers Have Documents That Prove Allergan Inc. (AGN) Misled Investors About Valeant (VRX): Ackman 10/17/2014
Shire Plummets As AbbVie (ABBV) Reconsiders $55 Billion Takeover Bid 10/16/2014
MorphoSys AG Acquires Lanthipeptide Technology From Lanthio Pharma 10/15/2014
Princeton University Acquires Protea Biosciences, Inc.'s LAESI® Technology Platform 10/15/2014
Spotlight Innovation Signs Letter Of Intent To Acquire Memcine Pharmaceuticals 10/15/2014
Analysts Still See AstraZeneca PLC (AZN) As Viable Takeover Target 10/15/2014
Geographic Split Likely For GlaxoSmithKline (GSK) Mature Drugs Sale 10/15/2014
Becton, Dickinson and Company (BDX) Acquires GenCell Biosystems 10/13/2014
Oxford BioMedica PLC (OXB.L) Acquires Windrush Court Office And Laboratory Facilities 10/13/2014
Fosun International Ltd. Pays $607 Million For Portuguese Hospital Chain 10/13/2014
Fidelity Ups Its Stake In Allergan Inc. (AGN) As Actavis (ACT) Bid Rumors Fly; Potential $60 Billion Deal 10/10/2014
Bay Area's IMPAX Laboratories, Inc. (IPXL) Snags Two Private Drugmakers For $700 Million Cash 10/10/2014
QLT Inc. (QLTI) Announces Merger With Auxilium Pharmaceuticals (AUXL) Terminates For Superior Proposal 10/9/2014
GlaxoSmithKline (GSK) Takes A 25% Stake In Aspen Pharmacare Ltd. Japanese Unit 10/9/2014
Roche (RHHBY) Acquires Rights To Technology And Patent Applications From Abvitro To Support Next-Generation Sequencing Pipeline 10/9/2014
Endo International plc (ENDP) Pays $2.6 Billion For Auxilium Pharmaceuticals (AUXL), Auxilium Drops QLT Inc. (QLTI) Deal 10/9/2014
Valeant (VRX) Will Sweeten Allergan Inc. (AGN) Bid To Clinch Deal 10/9/2014
Actavis (ACT) Plots New Merger Approach For Allergan Inc. (AGN) 10/8/2014
DiaGenic ASA Signed Final Agreement To Acquire NEL Hydrogen AS – Extended Announcement 10/8/2014
Teva Pharmaceutical Industries Limited (TEVA) To Stop R&D In Cancer And Women's Health; 14 Pipeline Projects To End, Divest 10/7/2014
Top Managers Argue Over What To Do With Sanofi (SAN.PA)'s $8 Billion Drug Portfolio 10/7/2014
Analyst Dismisses Teva Pharmaceutical Industries Limited (TEVA)-Mylan Inc. (MYL) Merger Rumor 10/7/2014
Cognizant (CTSH) Acquires Cadient Group To Help Clients Drive Business Transformation Through Digital Technologies 10/7/2014
Actavis (ACT) Finally Makes A Move, Pays $675 Million For Durata Therapeutics, Inc.  (DRTX) 10/6/2014
Week in Review: WuXi PharmaTech Co., Ltd. Acquires XenoBiotic Laboratories, Inc. , A US-China CRO 10/6/2014
Salix Pharmaceuticals, Ltd. (SLXP) Linked With Actavis (ACT) After Calling Off Cosmo Pharmaceuticals S.p.A. Merger Amid Inversion Crackdown 10/3/2014
Arbor Pharmaceuticals Explores $1 Billion+ Sale 10/3/2014
PAREXEL International (PRXL) Announces Acquisition Of Clinintel, Extending Leadership In Randomization And Trial Supply Management 10/3/2014
Soluble Therapeutics Grabs Seattle-Based Biotech Dilyx Biotechnologies 10/3/2014
Sagent Pharmaceuticals, Inc. Bags Omega Laboratories For $85.3 Million Cash 10/2/2014
Novasep To Sell Its Bahamian Plant To Local Investor 10/2/2014
The Dow Chemical Company (DOW) Provides Updates On Planned Divestments Progress And Outlines Additional Portfolio Actions 10/2/2014
Stemgent, Inc. Sells The Stem Cell Reagent And Services Business Unit 10/2/2014
Neogen Corporation (NEOG) Acquires BioLumix 10/2/2014
Prima Biomed (PRR.AX) Secures $37.4 Million To Fund Immutep S.A. Acquisition 10/2/2014
Catalent Pharma Solutions (CTLT) Expands Its Technology Offerings In Biologics, Acquires Redwood Bioscience Inc. And The SMARTag™ Technology Platform 10/2/2014
Immutep S.A. Picks Up Prima Biomed (PRR.AX) For $28 Million 10/2/2014
Johnson & Johnson (JNJ) Bags SSF's Alios BioPharma For $1.7 Billion Cash 10/1/2014
Akorn, Inc. (AKN) Ponies Up $45 Million Cash For Sunovion Pharmaceuticals Inc.'s Xopenex® (levalbuterol HCI) Inhalation Solution 10/1/2014
After Snagging 18 Products From AstraZeneca PLC (AZN), IGI Laboratories, Inc. Grabs Two More From Valeant (VRX) 10/1/2014
Oncore Grabs Enantigen Therapeutics For Undisclosed Amount 10/1/2014
Islet Sciences, BHV Pharma, Inc. Merges; Combined Company To Be Named Avogenx 10/1/2014
WuXi PharmaTech Co., Ltd. Laboratory Testing Division Expands In U.S. With Acquisition Of XenoBiotic Laboratories, Inc. 10/1/2014
Harvard Bioscience Inc. (HBIO) Acquires Multi Channel Systems MCS GmbH And Triangle BioSystems, Inc. 10/1/2014
Consort Medical Scoops Up Aesica For $374 Million 10/1/2014
Recipharm AB Completes Acquisition Of Corvette Pharmaceutical Services Group For SEK1.1 Billion 10/1/2014
Merck & Co. (MRK) Completes Sale Of Consumer Care Business To Bayer AG (BAYZF) For $14.2 Billion 10/1/2014
Chindex International, Inc. (CHDX) Completes Go-Private Transaction With Healthy Harmony Holdings, L.P. 9/30/2014
Cellular Biomedicine Group (CBMG) Completes Acquisition Of Agreen Biotech Co Ltd. 9/30/2014
Strides Arcolab Limited Snags Shasun Pharma In All Stock Deal Worth Over $221 Million 9/30/2014
Chiltern International Ltd. Acquires Pacific Clinical Research Pte Limited And Expands Operations And Therapeutic Depth In Asia-Pacific 9/29/2014
Ex-Elan Corporation PLC (ELN) Trio Snags Their Former Employer’s Kinase Inhibitor Program 9/29/2014
Daiichi Sankyo, Inc. (4568.t) Boosts Cancer Pipeline With $410 Million Ambit Biosciences Buy 9/29/2014
Hikma Pharmaceuticals Eyeing $1 Billion Bid For U.S. Rival CorePharma LLC 9/29/2014
Life Sciences M&A Stays White Hot As Buying Spree Continues 9/29/2014
AMAG Pharmaceuticals, Inc. (AMAG) Shells Out $675 Million For Women's Health Company Lumara Health 9/29/2014
Abbott Laboratories (ABT) Completes Acquisition Of CFR Pharmaceuticals; Announces Results Of Tender Offer For CFR Shares 9/26/2014
IGI Laboratories, Inc. Scores Eighteen Former Products From AstraZeneca PLC (AZN) 9/25/2014
Allergan Inc. (AGN) Issues Statement Regarding Recent Valeant Pharmaceuticals International (VRX) Correspondence 9/25/2014
PPD, Inc. (PPDI) Exercises Option To Acquire Remaining Interest In X-Chem 9/25/2014
Cambridge Healthtech Institute Announces The Acquisition Of OpenHelix 9/25/2014
Scleroderma Foundation Of Southern California And Greater San Diego Chapter Merge To Enhance Support And Education For Scleroderma Patients 9/25/2014
Pfizer (PFE) Approached Actavis (ACT) For Possible Merger 9/24/2014
Acorda Therapeutics (ACOR) Snaps Up Civitas Therapeutics In $525M Cash Deal 9/24/2014
Allergan Inc. (AGN) Rejected Actavis (ACT), Continues Courting Salix Pharmaceuticals, Ltd. (SLXP) 9/23/2014
Merck KGaA (MKGAF.PK) To Pay $17 Billion For St. Louis-Based Sigma-Aldrich Corporation (SIAL) 9/23/2014



//-->